Pervasis Receives FDA Fast Track Status for Vascugel® to Prevent Arteriovenous ... - PR-USA.net (press release) PDF Print
PR-USA.net (press release)
Vascugel has demonstrated clinical proof of concept in two Phase 2 clinical trials involving patients with ESRD who require a permanent arteriovenous (AV)

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.